CERTIFICATION PURSUANT TO 18 U.S.C. SECTION
1350, AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report
of Elite Pharmaceuticals, Inc. (the “Registrant”) on Form 10-Q for the quarter ended December 31, 2020 filed with
the Securities and Exchange Commission (the “Report”), I, Nasrat Hakim, Chief Executive Officer of the Registrant,
certify, pursuant to 18 U.S. C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
The Report fully complies with the requirements
of Section 13(a) of the Securities Exchange Act of 1934; and
Information contained in the Form 10-Q
fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
|Date: February 16, 2021
||/s/ Nasrat Hakim|
Chief Executive Officer, President and
Chairman of the Board
(Principal Executive Officer)
This certification has been furnished solely
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
A signed original of this written statement
required by Section 906 has been provided to Elite Pharmaceuticals, Inc. and will be retained by Elite Pharmaceuticals Inc. and
furnished to the Securities and Exchange Commission or its staff upon request.